EC Proceeds With Antitrust Probe Of French Drug Co.
The European Commission has dropped its claims that Servier SAS provided false and misleading information during an investigation, but will continue its probe of whether the French pharmaceutical company reached anti-competitive...To view the full article, register now.
Already a subscriber? Click here to view full article